This page shows results related to Alaway and Eye Inflammation from the FDA Adverse Event Reporting System (AERS). The adverse event Eye Inflammation has been reported to the FDA a total of 10 times for Alaway.
Learn More About Alaway Adverse EventsThe Proportional Reporting Ratio (PRR) for Alaway and Eye Inflammation is 114. The chart below compares this proportional reporting ratio of Eye Inflammation for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Eye Inflammation.
| Eye Inflammation | |
| Alaway | 50 |
NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.
Of those reporting Eye Inflammation, why were they taking Alaway?
| Eye Pruritus | 5 |
| Eye Allergy | 3 |
| Ocular Hyperaemia | 1 |
Which medications reported to the FDA are most commonly associated with Eye Inflammation?
| Avastin | 127 |
| Enbrel | 104 |
| Humira | 90 |
| Lucentis | 81 |
| Bevacizumab | 57 |
| Accutane | 55 |
| Kenalog-40 | 46 |
| Remicade | 32 |
| Fosamax | 27 |
| Xalatan | 26 |
| Botox | 23 |
 Show More |
